{"id":35759,"date":"2023-03-21T14:36:12","date_gmt":"2023-03-21T07:36:12","guid":{"rendered":"https:\/\/uns.ac.id\/en\/?p=35759"},"modified":"2023-03-21T14:36:15","modified_gmt":"2023-03-21T07:36:15","slug":"professor-of-fk-uns-launches-book-sitokin-dan-kemokin-biomarker-tuberkulosis-laten-cytokines-and-chemokines-biomarkers-of-latent-tuberculosis","status":"publish","type":"post","link":"https:\/\/uns.ac.id\/en\/professor-of-fk-uns-launches-book-sitokin-dan-kemokin-biomarker-tuberkulosis-laten-cytokines-and-chemokines-biomarkers-of-latent-tuberculosis\/","title":{"rendered":"Professor of FK UNS Launches Book \u2018Sitokin dan Kemokin: Biomarker Tuberkulosis Laten\u2019<\/em> (Cytokines and Chemokines: Biomarkers of Latent Tuberculosis)"},"content":{"rendered":"\n

UNS<\/a><\/strong> — Professor of the Faculty of Medicine (FK) Universitas Sebelas Maret (UNS) Surakarta, Prof. Dr. dr. Reviono, Sp.P(K) with Dr. dr. Bobby Singh, Sp.P., M.Kes., FISR, FAPSR launched the book \u2018Sitokin dan Kemokin: Biomarker Tuberkulosis Laten\u2019<\/em> (Cytokines and Chemokines: Biomarkers of Latent Tuberculosis). The book launch took place at UNS Inn, Sunday (19\/3\/2023),<\/p>\n\n\n\n

There were also several important figures: the former Director General of the Ministry of Health<\/a>, Prof. Dr. dr. Tjandra Yoga Aditama, Sp.P(K); Chairman of the Central Board of PDPI, Prof. Dr. dr. Agus Dwi Susanto, Sp.P(K); Head of the Ministry of Health’s Tuberculosis (TB) Working Team, dr. Tiffany Tiara Pakasi; Representative of the Indonesian Tuberculosis Eradication Association: dr. Lily Sri Wahyuni Sulistyowati; and the Indonesian Medical Council, dr. Vonny Nouva Tubasgu, Sp.Rad(K).<\/p>\n\n\n\n

Prof. Reviono, who is also the Dean of FK UNS, said that this was a form of product from the UNS Doctoral Program in Medical Sciences UNS.<\/p>\n\n\n\n

 \u201cThis book contains latent tuberculosis as part of the elimination of tuberculosis in Indonesia in 2035. The target is to stay 10% or experience a 90% reduction in TB sufferers since 2015 and the death rate will also be reduced by 95%,” he explained during a press conference.<\/p>\n\n\n\n

Furthermore, he explained that the incidence of TB begins with the entry of TB pathogenic germs. In most hosts it will respond adequately by the host immune system, limiting bacterial growth, and preventing infection. Not everyone who is exposed to TB pathogens will develop TB disease.<\/p>\n\n\n\n

 \u201cAbout 30% of people exposed to TB germs will be infected with TB, while 70% are not infected. Patients infected with TB, about 5%, will develop active TB within the first 1 year of infection and 95% will have latent TB infection. After 1 year, about 3-5% of patients with latent TB will develop active TB and the rest will continue to have latent TB throughout life,” he added.<\/p>\n\n\n\n

Dr. dr. Bobby Singh said that with these findings and novelty, hopefully this will become an effort to eradicate TB cases in Indonesia.<\/p>\n\n\n\n

“Through these cytokines and chemokines, hopefully those that have been making tests are expensive, we expect it will be cheaper and more effective,” he said.<\/p>\n\n\n\n